| Financial Year |
March 31 2023 |
| Monetary Funds |
33,567,026.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
35,640.00 |
| Accounts Receivable |
64,098,395.00 |
| Advances to Suppliers |
9,270,202.82 |
| Other Receivables |
8,497,358.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
50,134,458.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,792,624.06 |
| Total Current Assets |
168,395,705.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
70,362,365.56 |
| Investment Properties |
-- |
| Fixed Assetes |
24,146,633.34 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,571,896.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
658,403.04 |
| Deferred Income Tax Assets |
90,244.89 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
129,790,063.81 |
| Total Assets |
298,185,769.47 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
60,828,652.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,173,415.41 |
| Taxes Payable |
1,364,165.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,180,873.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,270,713.03 |
| Other Current Liabilities |
1,863,650.26 |
| Sub-Total of Current Liabilities |
126,861,620.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,546,028.60 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,364,947.34 |
| Total Liabilities |
137,226,567.70 |
| Paid-In Capital(Or Share Stock) |
144,010,000.00 |
| Capital Surplus |
347,753,860.00 |
| Surplus Reserve |
31,396,231.37 |
| LESS:Treasury Stock |
20,760,000.00 |
| Undistributed Profits |
-343,225,430.04 |
| Minority Stockholder's Interest |
3,784,540.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
157,174,661.33 |
| Owner's Equity（Stockholder's Equity） |
160,959,201.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
298,185,769.47 |
